Dr Reddy’s Begins Marketing Generic Ibandronate Sodium in US

by Kathy Jones on  July 3, 2012 at 7:47 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Indian drug maker Dr Reddy's Laboratories has confirmed that it has started marketing its anti-osteoporosis drug Ibandronate Sodium in the American market, which will be available in 150 mg dose tablet form.
 Dr Reddy’s Begins Marketing Generic Ibandronate Sodium in US
Dr Reddy’s Begins Marketing Generic Ibandronate Sodium in US

The generic version of Roche's Boniva, Ibandronate Sodium is used in treating post-menopausal osteoporosis. Dr Reddy's abbreviated new drug application (ANDA) was approved by the US Food and Drug Administration after the company had been locked in a legal battle with Roche over a patent dispute since 2007.

Boniva had managed to clock up sales of more than $486 million in the US market last year, according to figures released by IMS Health. Confirming the launch of the drug Dr Reddy's Laboratories said, "The tablets are available in the cartons of three blister packs containing 1 tablet each."



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Hyponatremia 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive